Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle B Rocque

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
JCO Oncology Practice|February 13, 2020
Health Insurance Literacy and Financial Hardship in Women Living With Metastatic Breast CancerCourtney P Williams, Maria Pisu, Andres Azuero, et al.
Future Oncology (London, England)|August 14, 2020
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancerDebasish Tripathy, Joanne L Blum, Gabrielle B Rocque, et al.
Cancer Medicine|November 30, 2021
Examining the association among fear of COVID-19, psychological distress, and delays in cancer careNicole E Caston, Valerie M Lawhon, Karen Lisa Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast CancerGabrielle B Rocque, Courtney P Williams, Bradford E Jackson, et al.
Science Translational Medicine|March 28, 2014
Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindlesLauren M Zasadil, Kristen A Andersen, Dabin Yeum, et al.
Cancer|October 15, 2018
Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasisGabrielle B Rocque, Courtney P Williams, Kelly M Kenzik, et al.
Future Oncology (London, England)|October 27, 2025
Real-world effectiveness of palbociclib plus hormone treatment and its impact on patient quality of life: a plain language summary of findings from POLARISDebu Tripathy, Joanne L Blum, Steven McCune, et al.
Journal of Psychosocial Oncology|December 15, 2022
Patient-reported discrimination among limited-resourced cancer survivors: a brief reportNicole E Caston, Austin R Waters, Courtney P Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2022
Cost-Effectiveness of Pharmacologic Treatment Options for Women With Endocrine-Refractory or Triple-Negative Metastatic Breast CancerStephanie B Wheeler, Jason Rotter, Anagha Gogate, et al.
Cancer|September 16, 2022
Associations between geography, decision-making style, and interest in cancer clinical trial participationNicole E Caston, Courtney P Williams, Clara Wan, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
JCO Oncology Practice|February 13, 2020
Health Insurance Literacy and Financial Hardship in Women Living With Metastatic Breast CancerCourtney P Williams, Maria Pisu, Andres Azuero, et al.
Future Oncology (London, England)|August 14, 2020
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancerDebasish Tripathy, Joanne L Blum, Gabrielle B Rocque, et al.
Cancer Medicine|November 30, 2021
Examining the association among fear of COVID-19, psychological distress, and delays in cancer careNicole E Caston, Valerie M Lawhon, Karen Lisa Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast CancerGabrielle B Rocque, Courtney P Williams, Bradford E Jackson, et al.
Science Translational Medicine|March 28, 2014
Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindlesLauren M Zasadil, Kristen A Andersen, Dabin Yeum, et al.
Cancer|October 15, 2018
Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasisGabrielle B Rocque, Courtney P Williams, Kelly M Kenzik, et al.
Future Oncology (London, England)|October 27, 2025
Real-world effectiveness of palbociclib plus hormone treatment and its impact on patient quality of life: a plain language summary of findings from POLARISDebu Tripathy, Joanne L Blum, Steven McCune, et al.
Journal of Psychosocial Oncology|December 15, 2022
Patient-reported discrimination among limited-resourced cancer survivors: a brief reportNicole E Caston, Austin R Waters, Courtney P Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2022
Cost-Effectiveness of Pharmacologic Treatment Options for Women With Endocrine-Refractory or Triple-Negative Metastatic Breast CancerStephanie B Wheeler, Jason Rotter, Anagha Gogate, et al.
Cancer|September 16, 2022
Associations between geography, decision-making style, and interest in cancer clinical trial participationNicole E Caston, Courtney P Williams, Clara Wan, et al.
Pageof 17